ALNY Snapshot
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts.
VALUATION DATA
Market Capitalization$19,170,869,000
Price to Sales9.00
Earnings per Share$-3.5200
PE RatioNone
PRICE DATA
Most Recent Close$149.4500
52 Week High$10.49
52 Week Low$142.92
50-Day Moving Average$10.01
200-Day Moving Average$-85.03
All data are from Alpha Vantage as of today. For more infomation on ALNY see Stock Dividend, Valuation, Price and Financial Data for Investors